首页> 外国专利> Pharmaceutical Composition of linagliptin and chlorine - 4 - (1 - B - D - glucopiranos - 1 - il) - 2 - 4 - ((S) - tetrahydrofuran-3-yl iloxi) benzyl - benzene, Pharmaceutical Form and Process for its preparation

Pharmaceutical Composition of linagliptin and chlorine - 4 - (1 - B - D - glucopiranos - 1 - il) - 2 - 4 - ((S) - tetrahydrofuran-3-yl iloxi) benzyl - benzene, Pharmaceutical Form and Process for its preparation

机译:利格列汀和氯的药物组合物-4-(1-B-D-葡萄糖吡喃糖-1-il)-2-[4-((S)-四氢呋喃-3-基伊洛西)苄基]-苯,药物形式和制备方法它的准备

摘要

Refers to a Pharmaceutical composition comprising: (a) 0.1 to 30mg of linagliptin as First Active Ingredient; (b) 0.5 to 100mg of a Second Active principle bencenico replaced with glucopiranosilo is a Derivative of formula (i) wherein R1 is Methyl or chlorine, R3 is etinilo, ethoxy Ethyl (R) - Iloxi tetrahydrofuran-3-yl or (S) - tetrahydrofuran-3-yl iloxi; (c) 40 to 88% of solvent; d) 0.5 to 20% of a Binder; and e) 0.5 to 20 percent of a disintegrant; where both active substances are in an amount of 0.5 to 25% by weight of the composition. The composition is useful for the treatment of Type 2 diabetes mellitus, hyperglycaemia, Obesity
机译:指包含以下成分的药物组合物:(a)0.1至30mg利格列汀作为第一活性成分; (b)0.5至100毫克被葡萄糖基吡喃西洛取代的第二种活性成分苄丝尼为式(i)的衍生物,其中R1为甲基或氯,R3为依替尼洛,乙氧基乙基(R)-碘代四氢呋喃-3-基或(S) -四氢呋喃-3-基伊洛西; (c)40至88%的溶剂; d)粘合剂的0.5%至20%; e)崩解剂的0.5%至20%;其中两种活性物质的含量为组合物重量的0.5%至25%。该组合物可用于治疗2型糖尿病,高血糖症,肥胖症

著录项

  • 公开/公告号PE00182012A1

    专利类型

  • 公开/公告日2012-02-12

    原文格式PDF

  • 申请/专利权人 BOEHRINGER INGELHEIM INTERNATIONAL GMBH;

    申请/专利号PE20110001438

  • 发明设计人 EISENREICH WOLFRAM;

    申请日2010-02-11

  • 分类号A61K31/522;A61K31/70;A61K31/7004;A61K31/7008;A61K45/06;A61P3/06;A61P3/08;A61P3/10;

  • 国家 PE

  • 入库时间 2022-08-21 17:23:25

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号